The significant recapitalization of the Americas’ leading CDMO for pharmaceutical oral solid dosage formulation and clinical supply manufacturing will accelerate growth, including the build-out of state-of-the-art laboratories and Good Manufacturing Practices-compliant facilities. May 24, 2022 – Trans-Atlantic private equity healthcare specialist ArchiMed is the lead investor in an alliance recapitalizing Corealis Pharma. ArchiMed and fellow […]